Luís Fernando Ferreira Cavalcante

Luís Fernando Ferreira Cavalcante

Auto-generated profile, based on publicly available information

Luís Fernando Ferreira Cavalcante

Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2025 in Jornal de Pediatria
Verified
Journal Article
Open access
LCLuís Fernando Ferreira Cavalcante
Luís Fernando Ferreira Cavalcante
GCGiovanna Costa
Giovanna Costa
SBSophia Massafelli Battistuta
Sophia Massafelli Battistuta
PMPedro Faria Makabe
Pedro Faria Makabe
IBIsadora Silva Fanucci Bueno
Isadora Silva Fanucci Bueno
MSMarco Aurelio Palazzi Safadi
Marco Aurelio Palazzi Safadi
This systematic review and meta-analysis aimed to evaluate the efficacy of surgical management, specifically total and partial tonsillectomy, for Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) syndrome, focusing on symptom resolution and recurrence reduction. A systematic search of MEDLINE, Scopus, and Cochrane databases identified randomized controlled trials (RCTs) comparing surgical to non-surgical management in children with PFAPA. Data extraction and quality assessment adhered to Cochrane guidelines and PRISMA protocols. Risk ratios (RR) and confidence intervals (CI) were calculated using random-effects models. After the removal of duplicates, 31 studies were screened and 3 studies were included. Pooled analysis revealed a 72% reduction in persistent symptoms following surgical interventions compared to non-surgical management (RR: 0.28, 95% CI: 0.12-0.68, I² = 22%, p = 0.005). The findings confirm that surgical management, including total and partial tonsillectomy, is an effective therapeutic option for PFAPA, with substantial benefits in symptom resolution and quality of life improvement. While surgery offers long-term benefits, its risks, and broader immunological implications require careful consideration. The study underscores the necessity for larger, multicenter trials to validate these findings across diverse populations and optimize treatment strategies.

1 December 2025 in Neurology Clinical Practice
Verified
Journal Article
Closed access
GCGiovanna Ristori Costa
Giovanna Ristori Costa
LCLuís Fernando Ferreira Cavalcante
Luís Fernando Ferreira Cavalcante
SBSophia Massafelli Battistuta
Sophia Massafelli Battistuta
PMPedro Faria Makabe
Pedro Faria Makabe
IBIsadora Silva Fanucci Bueno
Isadora Silva Fanucci Bueno
Diogo Haddad SantosDiogo Haddad Santos
Diogo Haddad Santos

7 May 2026 in BMC Urology
Verified
Journal Article
Open access
PDF file
PMPedro Faria Makabe
Pedro Faria Makabe
LCLuís Fernando Ferreira Cavalcante
Luís Fernando Ferreira Cavalcante
BYBruno Yuamoto
Bruno Yuamoto
SBSophia Massafelli Battistuta
Sophia Massafelli Battistuta
GCGiovanna Ristori Costa
Giovanna Ristori Costa
LTLuis Gustavo Morato de Toledo
Luis Gustavo Morato de Toledo
Tranexamic acid (TXA) is an antifibrinolytic agent with demonstrated benefits in various surgical procedures, including urological surgeries. However, its

28 April 2025 in Transplantation Proceedings
Verified
Journal Article
Closed access
LCLuís Fernando Ferreira Cavalcante
Luís Fernando Ferreira Cavalcante
APAlonzo Armani Prata
Alonzo Armani Prata
CLCaio Rezende Lima
Caio Rezende Lima
GSGabriela Blanco Stutz
Gabriela Blanco Stutz
TMThalia Melamed
Thalia Melamed
ABAlexandra Régia Dantas Brígido
Alexandra Régia Dantas Brígido

1 January 2026 in Revista do Colégio Brasileiro de Cirurgiões
Verified
Journal Article
Open access
SBSophia Massafelli Battistuta
Sophia Massafelli Battistuta
LCLuís Fernando Ferreira Cavalcante
Luís Fernando Ferreira Cavalcante
GCGiovanna Ristori Costa
Giovanna Ristori Costa
PMPedro Faria Makabe
Pedro Faria Makabe
BYBruno Yuamoto
Bruno Yuamoto
JAJose Cesar Assef
Jose Cesar Assef
Introduction: While the conservative management of blunt liver injuries is well established in the medical literature, with reported success rates ranging from 82% to 100% in hemodynamically stable patients, its application to penetrating injuries remains controversial due to perceived risks. This study aims to assess the potential outcomes of non-operative management (NOM) in selected patients with penetrating liver injuries compared to operative management (OM). Methods: A systematic review and meta-analysis of observational studies comparing NOM and OM in patients with penetrating liver injuries was conducted using the Medline, Scopus, and Cochrane databases, in accordance with the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Results: Six observational studies comprising 4,407 patients were included. NOM was associated with lower mortality (RR 0.40; 95% CI 0.31-0.53; I2=0%; p<0.01) and complication rates (RR 0.83; 95% CI 0.75-0.91; I2=0%; p<0.01). No statistically significant difference was observed in liver complications (RR 0.25; 95% CI 0.01-12.47; I2=0%; p=0.10), blood transfusion (RR 0.73; 95% CI 0.0-1741.82; I2=84%; p=0.73), and hospital length of stay (RR -0.44; 95% CI -6.76-5.87; I2=0%; p=0.83). Conclusion: Non-operative management of penetrating liver injuries, when compared to operative management, may be considered a possible alternative for selected patients.

26 December 2025 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
APAlonzo Armani Prata
Alonzo Armani Prata
LCLuís Fernando Ferreira Cavalcante
Luís Fernando Ferreira Cavalcante
GSGabriela Blanco Stutz
Gabriela Blanco Stutz
TMThalia Melamed
Thalia Melamed
CLCaio Rezende Lima
Caio Rezende Lima
ABAlexandra Régia Dantas Brígido
Alexandra Régia Dantas Brígido